Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Treatment Refusal | 2 | 2015 | 20 | 0.990 |
Why?
|
| Prostate-Specific Antigen | 1 | 2023 | 118 | 0.830 |
Why?
|
| Colorectal Neoplasms | 4 | 2023 | 441 | 0.790 |
Why?
|
| Hospitals, General | 1 | 2015 | 5 | 0.550 |
Why?
|
| Insurance Coverage | 1 | 2015 | 100 | 0.510 |
Why?
|
| Thiocarbamates | 1 | 2014 | 4 | 0.490 |
Why?
|
| Length of Stay | 1 | 2015 | 185 | 0.490 |
Why?
|
| Androstadienes | 1 | 2014 | 18 | 0.490 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 113 | 0.480 |
Why?
|
| Prostatic Neoplasms | 1 | 2023 | 935 | 0.470 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2015 | 182 | 0.450 |
Why?
|
| Patient Dropouts | 1 | 2013 | 29 | 0.440 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 560 | 0.380 |
Why?
|
| Breast Neoplasms | 5 | 2022 | 1502 | 0.350 |
Why?
|
| Mental Disorders | 1 | 2013 | 309 | 0.330 |
Why?
|
| Early Detection of Cancer | 4 | 2023 | 336 | 0.290 |
Why?
|
| United States | 7 | 2024 | 4223 | 0.280 |
Why?
|
| Substance-Related Disorders | 1 | 2013 | 730 | 0.260 |
Why?
|
| Mass Screening | 3 | 2023 | 462 | 0.250 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 2379 | 0.240 |
Why?
|
| Health Care Surveys | 2 | 2015 | 136 | 0.240 |
Why?
|
| Mastectomy, Segmental | 3 | 2022 | 17 | 0.240 |
Why?
|
| Patient Discharge | 2 | 2015 | 93 | 0.240 |
Why?
|
| Aged | 7 | 2022 | 6741 | 0.240 |
Why?
|
| Treatment Outcome | 3 | 2018 | 1369 | 0.220 |
Why?
|
| Humans | 14 | 2024 | 37093 | 0.210 |
Why?
|
| Health Policy | 1 | 2024 | 165 | 0.210 |
Why?
|
| Communication | 1 | 2023 | 180 | 0.200 |
Why?
|
| Sex Factors | 2 | 2015 | 898 | 0.190 |
Why?
|
| Decision Making | 1 | 2023 | 203 | 0.190 |
Why?
|
| Young Adult | 3 | 2015 | 4268 | 0.180 |
Why?
|
| Mental Health | 1 | 2024 | 303 | 0.180 |
Why?
|
| Female | 9 | 2022 | 20969 | 0.180 |
Why?
|
| Adolescent | 3 | 2015 | 5363 | 0.180 |
Why?
|
| Middle Aged | 5 | 2023 | 10129 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 2 | 2022 | 144 | 0.170 |
Why?
|
| Male | 5 | 2023 | 20025 | 0.170 |
Why?
|
| Survival Analysis | 2 | 2018 | 325 | 0.160 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2018 | 33 | 0.160 |
Why?
|
| Receptor, erbB-2 | 2 | 2018 | 133 | 0.150 |
Why?
|
| Adult | 4 | 2022 | 11712 | 0.140 |
Why?
|
| Hormones | 1 | 2015 | 55 | 0.130 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 441 | 0.120 |
Why?
|
| Retrospective Studies | 2 | 2022 | 2026 | 0.120 |
Why?
|
| Sirolimus | 1 | 2014 | 60 | 0.120 |
Why?
|
| Receptors, Progesterone | 1 | 2014 | 81 | 0.120 |
Why?
|
| Receptors, Estrogen | 1 | 2014 | 156 | 0.110 |
Why?
|
| Urban Population | 1 | 2015 | 333 | 0.110 |
Why?
|
| Logistic Models | 1 | 2015 | 923 | 0.110 |
Why?
|
| Medically Uninsured | 1 | 2013 | 56 | 0.110 |
Why?
|
| Residence Characteristics | 1 | 2015 | 322 | 0.100 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 1067 | 0.100 |
Why?
|
| Medicaid | 1 | 2013 | 109 | 0.100 |
Why?
|
| Patient Compliance | 1 | 2013 | 212 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2015 | 854 | 0.090 |
Why?
|
| Age Factors | 1 | 2013 | 1033 | 0.090 |
Why?
|
| Obesity | 1 | 2015 | 1067 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 664 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2023 | 864 | 0.060 |
Why?
|
| Workers' Compensation | 1 | 2024 | 6 | 0.060 |
Why?
|
| State Government | 1 | 2024 | 13 | 0.060 |
Why?
|
| Mental Health Services | 1 | 2024 | 118 | 0.050 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2022 | 44 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 268 | 0.050 |
Why?
|
| Attitude to Health | 1 | 2023 | 325 | 0.050 |
Why?
|
| Medicare | 1 | 2022 | 195 | 0.050 |
Why?
|
| Focus Groups | 1 | 2021 | 348 | 0.040 |
Why?
|
| Public Health | 1 | 2022 | 372 | 0.040 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2016 | 16 | 0.040 |
Why?
|
| Propensity Score | 1 | 2016 | 38 | 0.040 |
Why?
|
| Hormone Replacement Therapy | 1 | 2016 | 41 | 0.040 |
Why?
|
| Minority Groups | 1 | 2022 | 596 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 148 | 0.030 |
Why?
|
| Vinblastine | 1 | 2015 | 9 | 0.030 |
Why?
|
| Michigan | 1 | 2015 | 22 | 0.030 |
Why?
|
| Drug Therapy | 1 | 2015 | 17 | 0.030 |
Why?
|
| Taxoids | 1 | 2015 | 37 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 275 | 0.030 |
Why?
|
| Social Class | 1 | 2015 | 247 | 0.030 |
Why?
|
| Life Style | 1 | 2015 | 308 | 0.030 |
Why?
|
| Exercise | 1 | 2015 | 613 | 0.020 |
Why?
|